3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
7
Prostatic Neoplasms
6
Hematopoietic and Lymphatic System Neoplasm
6
Hematologic Neoplasms
6
Colorectal Neoplasms
5
Breast Neoplasms
5
Anatomic Stage I Breast Cancer AJCC v8
5
Pancreatic Neoplasms
3
Neoplasms
3
Malignant Solid Neoplasm
3
Leukemia, Myeloid, Acute
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Head and Neck Carcinoma
2
Glioma
2
Carcinoma, Renal Cell
2
Carcinoma
2
COVID-19
2
Uveal Melanoma
1
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Tonsillar Neoplasms
1
Tongue Neoplasms
1
Teratoma
1
Stomatitis
1
Interventions
Fluorouracil
13
pembrolizumab
12
Paclitaxel
12
Oxaliplatin
12
Leucovorin
9
Carboplatin
9
Capecitabine
8
Trastuzumab
7
Nivolumab
7
Cisplatin
7
Radiotherapy
6
Radiation
6
Taxes
5
Esophagectomy
5
Drug Therapy
5
Surgical Procedures, Operative
4
Specimen Handling
4
Irinotecan
4
trastuzumab deruxtecan
3
tislelizumab
3
patritumab deruxtecan
3
Radiotherapy, Intensity-Modulated
3
Proton Therapy
3
Immunotherapy
3
zanidatamab
2
ulixertinib
2
trastuzumab biosimilar HLX02
2
relatlimab
2
durvalumab
2
atezolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Practice Guidelines as Topic
×
90 days
×
Clear all
No trials found.